InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Smith David Ross, 首席财务官. Officer active across 3 companies, notably Charles River Laboratories International, INC.. Cumulatively, 10 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €208k. Activity tracked since 4 May 2021. The latest transaction was filed on 20 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Smith David Ross
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
6,598 股0Common StockSEC:0001965040-26-000103:0
7,282 股0Common StockSEC:0001127602-25-014752:0
6,354 股0Common StockSEC:0001127602-24-020752:0
3,846 股@ US$109.340.0052% mcap29.6% 占其流量Common StockSEC:0001127602-22-008258:0
5,152 股0Common StockSEC:0001127602-22-007805:0
341 股@ US$293.610.0012% mcap6.9% 占其流量Common StockSEC:0001127602-22-006654:0
12,321 股0Common StockSEC:0001127602-22-002781:0
600 股@ US$406.358419.4% 占其流量Common StockSEC:0001127602-21-023436:0
1,313 股0Common StockSEC:0001127602-21-018615:0
3,305 股@ US$144.6737.1% 占其流量Common StockSEC:0001127602-21-015655:0
10 条申报中的 10 条
About Smith David Ross
Smith David Ross is Chief Financial Officer and Executive Vice President at Charles River Laboratories International, Inc. He oversees the financial operations of the company, ensuring financial health and compliance.
